The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
Open accessAbstract
Migraine is a disabling neurological disease that affects 14.7 % of Europeans. Studies evaluating the economic impact of migraine are complex to conduct adequately and with time become outdated as healthcare systems evolve. This study sought to quantify and compare direct medical costs of chronic migraine (CM) and episodic migraine (EM) in five European countries. Cross-sectional data collected via a web-based survey were screened for migraine and classified as CM (≥15 headache days/month) or EM (<15 headache days/month), and included sociodemographics, resource use data and medication use. Unit cost data, gathered using publicly available sources, were analyzed for each type of service, stratified by migraine status. Univariate and multivariate log-normal regression models were used to examine the relationship between various factors and their impact on total healthcare costs. This economic analysis included data from respondents with migraine in the UK, France, Germany, Italy, and Spain. CM participants had higher level of disability and more prevalent psychiatric disorders compared to EM. CM participants had more provider visits, emergency department/hospital visits, and diagnostic tests; the medical costs were three times higher for CM than EM. Per patient annual costs were highest in the UK and Spain and lower in France and Germany. CM was associated with higher medical resource use and total costs compared to EM in all study countries, suggesting that treatments that reduce headache frequency could decrease the clinical and economic burden of migraine in Europe. Comparing patterns of care and outcomes among countries may facilitate the development of more cost-effective care, and bring greater recognition to patients affected by migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, no detailed assessment of the current treatment pathway, impact on work productivity, or burden associated with premonitory and postdromal phases of migraine is available in individuals experiencing ≥4 MMDs who have had previous prophylactic treatments that failed and continue to experience frequent migraines.”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
In the citing paper
“However, the current understanding of migraine burden among individuals with the highest unmet needs, specifically those experiencing ≥4 monthly migraine days (MMDs) and prior prophylaxis failure, is limited.”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
In the citing paper
“These findings are consistent with the results of the IBMS study, which found that for each of the five European countries studied, chronic migraine (per ICHD-2 criteria, persons with ≥15 MMDs) was associated with additional healthcare costs attributable to an increased use of medical services and associated cost [6].”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Self-citationStewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Self-citationNew Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909 · cited 1×
“1 defines chronic migraine as C15 headache days per month for at least 3 months, with C8 days per month fulfilling criteria for migraine without aura, in the absence of medication overuse and that cannot be attributed to another causative disorder [6].”
BackgroundSelf-citationBIGAL, M. E., Serrano, D., Buse, D. C., Scher, I., Stewart, W. F., & Lipton, R. B. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01217.x · Cited by 848
Self-citationThe cost of headache disorders in Europe: the Eurolight project
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri‐Minet, M., Rastenyte, D., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03612.x · Cited by 741
Self-citationGlobal prevalence of chronic migraine: A systematic review
Natoli, J. L., Manack, A., Dean, B. B., Butler, Q. R., Turkel, C., Stovner, L., & Lipton, R. B. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01941.x · Cited by 693
Self-citationAn international study to assess reliability of the Migraine Disability Assessment (MIDAS) score
Stewart, W. F., Lipton, R. B., Whyte, J., Dowson, A. J., Kolodner, K. B., Liberman, J. N., & Sawyer, J. P. C. (1999) · Neurology · doi:10.1212/wnl.53.5.988 · Cited by 629
Self-citationBlumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627
Self-citationSociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
Buse, D. C., Manack, A., Serrano, D., Turkel, C., & Lipton, R. B. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.192492 · Cited by 622
Self-citationClassification of daily and near-daily headaches
Silberstein, S. D., Lipton, R. B., & Sliwinski, M. J. (1996) · Neurology · doi:10.1212/wnl.47.4.871 · Cited by 613
Self-citation
Research works printed but not linked: 2
- Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB (2011) Prevalence of chronic migraine (CM), headache-related disability and sociodemographic factors in the US population. Headache 51(S1):28
- Michel P, Auray J, Chicoye A, Dartigues J, Lamure M, Duru G, Henry P, Salamon R (1993) Prise en charge des migraineux en France: coût et recours aux soins. J d’Econ Méd 11:71–80
Cited by
Sorted by citations
Items 201–300 of 336
Riise, J., Cambron‐Mellott, M. J., Zhang, Z., Huber, V., Pfau, A., Yue, L., Dwibedi, N., Olopoenia, A., & Geoffroy, P. A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119403 · Cited by 7
Revisiting dose-finding of monoclonal antibodies in migraine
Al‐Hassany, L., Karsan, N., Lampl, C., Goadsby, P. J., & MaassenVanDenBrink, A. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01602-4 · Cited by 7
Self-citationDeciphering the task ofN-acetyl aspartate in migraine
Lionetto, L., Capi, M., Vignaroli, G., Negro, A., & Martelletti, P. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.97 · Cited by 7
Self-citationIrimia, P., Lasaosa, S. S., García-Bujalance, L., Pinazo, L. R., Rubio-Rodríguez, D., & Rubio‐Terres, C. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1768850 · Cited by 7
Low-value care practice in headache: a Spanish mixed methods research study
Pozo‐Rosich, P., Layos-Romero, A., Martín-Delgado, J., Pascual, J., Bailón, C., Tentor, A., Pérez, A. S., Ignacio, E., Torres, A. M., & Mira, J. J. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01147-w · Cited by 7
Self-citationKarimi, E., Tirani, S. A., Azimi, E. S., Askari, G., As’habi, A., & Arab, A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1117740 · Cited by 7
Trigo-López, J., Peral, Á. L. G., Sierra, Á., Martínez‐Pías, E., Gutiérrez-Sánchez, M. J., Huzzey, E., & García‐Azorín, D. (2021) · BMC Neurology · doi:10.1186/s12883-021-02220-w · Cited by 7
Fernández‐Ferro, J., Ordás, C., Rejas, J., Ferro-Rey, B., Gómez-Lus, S., & Andrés, J. M. L. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.06.002 · Cited by 6
Agosti, R. M., Parzini, C., Findling, O., Myers, P., Petersen, J. A., Ryvlin, P., Sándor, P. S., Stallmach, M., Zecca, C., Snellman, J., et al. (2023) · Pain and Therapy · doi:10.1007/s40122-023-00484-3 · Cited by 6
Rattanawong, W., Anukoolwittaya, P., Hiransuthikul, A., Pongpitakmetha, T., Trisataya, A., Thanprasertsuk, S., & Rapoport, A. M. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01952-1 · Cited by 6
Economic burden of migraine in Singapore
Ong, J. J. Y., Patnaik, D., Chan, Y. C., Simon, O., & Finkelstein, E. A. (2020) · Cephalalgia Reports · doi:10.1177/2515816320908241 · Cited by 6
Gonçalves, A. S. O., Пантели, Д., Neeb, L., Kurth, T., & Aigner, A. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01342-9 · Cited by 7
Calandre, E. P., Garcia‐Leiva, J. M., & Ordóñez-Carrasco, J. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19158964 · Cited by 6
Dermitzakis, E. V., Argyriou, A. A., Bilias, K., Barmpa, E., Liapi, S., Rikos, D., Xiromerisiou, G., Soldatos, P., & Vikelis, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102768 · Cited by 6
Volta, G. D., Zavarize, P., Ngonga, G., & Pezzini, A. (2017) · International Journal of Neurology and Brain Disorders · doi:10.15436/2377-1348.17.1630 · Cited by 6
Temporal distribution of emergency room visits in patients with migraine and other headaches
García‐Azorín, D., Abelaira-Freire, J., Rodríguez‐Adrada, E., González-García, N., Planchuelo‐Gómez, Á., Peral, Á. L. G., Porta-Etessam, J., & Martín‐Sánchez, F. J. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1906222 · Cited by 6
Zavarise, P., & Volta, G. D. (2017) · OALib · doi:10.4236/oalib.1103660 · Cited by 6
Chronic migraine: a therapeutic challenge for clinicians
Irimia, P., Carmona‐Abellán, M., & Martínez‐Vila, E. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.726612 · Cited by 6
Wei, D., Wong, L. P., He, X., & Loganathan, T. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01763-w · Cited by 5
The Hidden Risks of Medication Underuse in Migraine Progression
Moon, H., & Chung, P. (2025) · Headache and Pain Research · doi:10.62087/hpr.2025.0019 · Cited by 5
Update of French migraine epidemiology: A narrative review
Lantéri‐Minet, M., & Lucas, C. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.10.006 · Cited by 5
Perrone, V., Veronesi, C., Giacomini, E., Andretta, M., Dell'orco, S., Sarro, G. D., Lena, F., Menti, A. M., Naclerio, M., Ritrovato, D., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1835850 · Cited by 5
Instrumental Exams Performance Can Be a Contributing Factor to the Delay in Diagnosis of Migraine
Viticchi, G., Bartolini, M., Falsetti, L., Dolcini, J., Cerqua, R., Luzzi, S., Provinciali, L., & Silvestrini, M. (2013) · European Neurology · doi:10.1159/000354164 · Cited by 5
Botulinum toxin for migraine treatment
Summ, O., Evers, S., & Husstedt, I. W. (2013) · doi:10.2217/ebo.12.230 · Cited by 5
Interneuronal dynamics facilitate the initiation of spike block in cortical microcircuits
Stein, W., & Harris, A. L. (2022) · Journal of Computational Neuroscience · doi:10.1007/s10827-022-00815-x · Cited by 4
“Headache yesterday” at work. Pilot study of headache impact in an active workforce
Gil‐Gouveia, R. (2021) · Revue Neurologique · doi:10.1016/j.neurol.2020.12.013 · Cited by 4
Monterrey, P., González, M., Ramirez, D. A., Gracia, F., Henríquez, F., Perez-Franco, E., Díaz, A., Vásquez, J. F., Benzadón, A., Obage, J., et al. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14375 · Cited by 4
Migraine Patient Care Model Preferences in a Community Practice
Stern, J. I., Ebbert, J. O., Vierkant, R. A., & Young, N. P. (2023) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200131 · Cited by 4
Algo se mueve en la migraña crónica
Cernuda‐Morollón, E., & Gómez, J. P. (2014) · Revista de Neurología · doi:10.33588/rn.5801.2013470 · Cited by 4
Pascual, J. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.01.010 · Cited by 4
Self-citationWolters, S., Carpay, J. A., Pronk, M. H., Zuurbier, K. W. M., Driessen, M. T., Lyras, L., & Postma, M. J. (2024) · BMC Neurology · doi:10.1186/s12883-024-03697-x · Cited by 3
Barbanti, P., Awad, S. F., Rae‐Espinoza, H., Régnier, S. A., Lee, X. Y., & Goadsby, P. J. (2024) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-024-00813-w · Cited by 3
Self-citationMigraine and ergot use increase plasma pentraxin 3 levels: an Egyptian study
Fahmy, E. M., Nada, M., Hamid, N. A. A. E., Sharaf, S. A. E.-A., Osama, W., & Elshebawy, H. (2025) · Neurological Research · doi:10.1080/01616412.2025.2456708 · Cited by 3
Headache Gauge: a real-life calendar-based tool for headache monitoring
Gil‐Gouveia, R., Marques, I. B., Parreira, E., Martins, I. P., & Oliveira, A. G. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05080-x · Cited by 4
Saigoh, K., Takeshima, T., Nakai, M., Shibasaki, Y., Ishida, M., Ning, X., Barash, S., Isogai, Y., & Koga, N. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393854 · Cited by 3
Mainardi, F., Merlo, P., Maggioni, F., Zanchin, G., & Volta, G. D. (2018) · OALib · doi:10.4236/oalib.1104765 · Cited by 3
Unidades especializadas de cefalea, una alternativa viable en España
Pozo‐Rosich, P., Martín-Delgado, J., Layos-Romero, A., Gómez, J. P., Bailón, C., Peral, Á. L. G., Ignacio, E., Torres, A., & Mira, J. J. (2020) · Revista de Neurología · doi:10.33588/rn.7106.2020269 · Cited by 3
Mitsikostas, D. D., Awad, S. F., Kongerslev, R., Pickering, L., Lee, X. Y., Phul, R., & Sacco, S. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03348-8 · Cited by 2
Malhi, G. K., Ita, K. B., Morra, M. J., & Popova, I. E. (2018) · Frontiers in Nanoscience and Nanotechnology · doi:10.15761/fnn.1000168 · Cited by 2
CURRENT APPROACHES TO THERAPY OF CHRONIC DAILY HEADACHE
Ekusheva, E. V. (2017) · Siberian medical review · doi:10.20333/2500136-2017-1-93-98 · Cited by 2
The Burden of Migraine in Real Clinical Practice: Clinical and Economic Aspects
Наприенко, М. В., Smekalkina, L. V., Сафонов, М. И., Filatova, E. G., Владимировна, Л. Н., Ekusheva, E. V., Artemenko, A. R., Osipova, V. В., & Baiushkina, L. I. (2019) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-019-00862-5 · Cited by 2
Real-World Treatment and Associated Healthcare Resource Use Among Migraine Patients in Germany
Hardtstock, F., Katsarava, Z., Wilke, T., Kocaata, Z., Kirchmann, T., Maywald, U., & Eberhardt, A. (2021) · doi:10.30756/ahmj.2020.04.04 · Cited by 2
Self-citationDíaz-Insa, S., Lasaosa, S. S., Driessen, M. T., Cohen, J. M., Lee, L., & Goadsby, P. J. (2024) · Acta Neurologica Scandinavica · doi:10.1155/ane/4714514 · Cited by 2
Self-citationLasmiditan For Acute Migraine Treatment
Neeb, L., & Reuter, U. (2013) · Future Neurology · doi:10.2217/fnl.13.45 · Cited by 2
Annequin, D., Tourniaire, B., & Amouroux, R. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0235-0_3 · Cited by 2
Societal impact of migraine chronification
Igarashi, H. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.1225 · Cited by 2
Novel Approaches in Migraine Treatment
Diener, H. (2013) · doi:10.2217/9781780842349 · Cited by 2
Ezeala‐Adikaibe, B., Onyekonwu, C. L., Ijoma, U. N., Mbadiwe, N., Ekenze, O. S., Orjioke, C., Young, E. E., Chime, P. E., Onodugo, O. D., Anyim, O. B., et al. (2018) · World Journal of Neuroscience · doi:10.4236/wjns.2018.84032 · Cited by 2
Filipović, B., de Ru, J. A., & Lohuis, P. J. F. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29505-9_10 · Cited by 2
Sivanandy, P., ROSMAN, A. N., SHAPHERI, A. D., CHEW, T. T., Lau, N. J. X., YEONG, M. Z. Y., ONG, M., MEETOOA, B. M. U. H., NG, E., Krishnasamy, K., et al. (2020) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2020v12i7.37440 · Cited by 2
Castaño‐Amores, C., Nieto-Gómez, P., Nieto-Sánchez, M. T., & Álvarez-Sánchez, R. (2022) · Ars Pharmaceutica (Internet) · doi:10.30827/ars.v63i4.23848 · Cited by 2
Épidémiologie et impact des céphalées
Lantéri‐Minet, M. (2015) · Elsevier eBooks · doi:10.1016/b978-2-294-73953-8.00002-x · Cited by 2
The socio-economic burden of migraine: yesterday and today
Семёнович, Я. И., & Filatova, E. G. (2024) · Medical alphabet · doi:10.33667/2078-5631-2024-21-13-17 · Cited by 1
Development of a healthcare utilisation index to compare patients worldwide: a cross-sectional study
John, G., Rebell, D., & Donzé, J. D. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13029-5 · Cited by 1
Olthof, A. W., Shiraliyeva, R. К., Aliyev, R. R., Mammаdbayli, A. K., van Ooijen, P. M. A., & de Groot, J. C. (2018) · NATIONAL JOURNAL OF NEUROLOGY · doi:10.28942/nnj.v0i0.247 · Cited by 1
Primary headaches as the reason for consultation in Primary Care: a prospective study
Rivera, I., Fontanillas, N., Cadelo, L., & Pascual, J. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.10.004 · Cited by 1
Self-citationEmerging Genomic Biomarkers In Migraine
Menon, S., & Griffiths, L. R. (2012) · Future Neurology · doi:10.2217/fnl.12.80 · Cited by 1
Las cefaleas primarias como motivo de consulta en Atención Primaria: un estudio prospectivo
Rivera, I., Fontanillas, N., Cadelo, L., & Pascual, J. (2025) · Neurología · doi:10.1016/j.nrl.2023.07.002 · Cited by 1
Self-citationShift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
Diener, H., Day, K. A., Lipsius, S., Aurora, S. K., Hindiyeh, N. A., & Detke, H. C. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01956-x · Cited by 1
Diagnosis of refractory forms of chronic primary headache
Ekusheva, E. V., Artemenko, A. R., & Osipova, V. В. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20171171248-53 · Cited by 1
The Migraine Patient in the Emergency Department
Orr, S. L., & Rowe, B. H. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316819388.008 · Cited by 1
Epidemiology of Headache in the Emergency Department
Orr, S. L., & Dodick, D. W. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316819388.003 · Cited by 1
Economic Impact of Chronic Headaches
Pace, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-91491-6_22 · Cited by 1
Chronic Daily Headache: Do We Know It When We See It?
Teckchandani, S., & Cowan, R. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-91491-6_1 · Cited by 1
Doležil, D., Marková, J., Klimeš, J., Počíková, Z., Dostál, F., Štěpánová, R., & Svobodník, A. (2020) · Journal of Pain Research · doi:10.2147/jpr.s273119 · Cited by 1
Florêncio, L. L. (2013) · doi:10.11606/d.17.2013.tde-02072015-043346 · Cited by 1
Migraine: Diagnosis, Treatment and Understanding c.1960–2010
Overy, C., & Em, T. (2014) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1
Costo beneficio del tratamiento de la migraña crónica con Onabotulinumtoxin A en Argentina
Buonanotte, C. F. (2014) · Neurología Argentina · doi:10.1016/j.neuarg.2014.11.001
Neurostimulators For the Treatment of Primary Headaches
Leone, M., Cecchini, A. P., Franzini, A., & Bussone, G. (2013) · Future Neurology · doi:10.2217/fnl.13.23
Current aspect of the diagnosis and management of migraine
Koreshkina, M. I. (2013) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2013-2421
Klinische Effektivität einer osteopathischen Behandlung bei Migräne
Cerritelli, F., Ginevri, L., Messi, G., Caprari, E., Vincenzo, M. D., Renzetti, C., Cozzolino, V., Barlafante, G., Foschi, N., & Provinciali, L. (2016) · Osteopathische Medizin · doi:10.1016/s1615-9071(16)60005-9
Pathophysiologie und Therapie der chronischen Migräne
Eren, O. E., & Straube, A. (2014) · NeuroTransmitter · doi:10.1007/s15016-014-0568-x
Mapoure, Y. N., Luma, N. H., Nkouonlack, C., Pokossy, A. V., & Mouelle, A. S. (2015) · HIV/AIDS Research and Treatment - Open Journal · doi:10.17140/hartoj-2-105
Kopfschmerztherapie – Schmerztherapie
Förderreuther, S., & Straube, A. (2014) · Der Schmerz · doi:10.1007/s00482-014-1418-2
Führt der Kopfschmerz zu relevanten Einschränkungen?
Malzacher, V. (2012) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-012-0498-z
Characterising the relationship between migraine and depression
Yang, Y. (2016) · Queensland University of Technology · doi:10.5204/thesis.eprints.101792
Gerring, Z. F. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.112796
Migraine: the relevance of inflammatory co-morbidity and genetic disposition
Birringer, C. (2013) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010000435
Lantéri‐Minet, M., Demarquay, G., Alchaar, H., Bonnin, J., Cornet, P., Douay, X., Dousset, V., Géraud, G., Guillouf, V., Navez, M. L., et al. (2014) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2014.06.008
Lantéri‐Minet, M., Demarquay, G., Alchaar, H., Bonnin, J., Cornet, P., Douay, X., Dousset, V., Géraud, G., Guillouf, V., Navez, M. L., et al. (2014) · Douleur et Analgésie · doi:10.1007/s11724-014-0380-1
Lebensqualität steigt, Inanspruchnahme von Gesundheitsleistungen sinkt
Kollewe, K., Gaul, C., Gendolla, A., & Sommer, K. (2021) · Schmerzmedizin · doi:10.1007/s00940-021-3195-1
Letter to the Editor: The Case for Publicly Funded Headache Surgery in Germany
Knoedler, L., Chartier, C., ElHawary, H., Kehrer, A., & Muehlberger, T. (2021) · JPRAS Open · doi:10.1016/j.jpra.2021.09.001
Erenumab in Mechanism-based Migraine Treatment
Özge, A., Uludüz, D., Karadaş, Ö., & Bozkurt, M. M. (2021) · Turkish Journal Of Neurology · doi:10.4274/tnd.2021.08784
Iparraguirre, S. T. (2014) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(14)70764-9
Martelletti, P. (2022) · Springer eBooks · doi:10.1007/978-3-030-97359-9_1
Self-citationO que é a enxaqueca crónica? Ó? Princípios fisiopatológicos e abordagem terapêutica
de Oliveira, R., Palavra, F., & Gil‐Gouveia, R. (2023) · Revista Dor · doi:10.24875/dor.22000007
Identification of Neutrophil/Lymphocyte Ratio as a Unique Biomarker for Migraine Follow-up
Uygur-Kucukseymen, E., & Akça, G. (2023) · Medical Records · doi:10.37990/medr.1212126
Clinical Instruments for Disability, Impact and Burden in Headache and Migraine
Demirci, S., & Uludüz, D. (2023) · Headache · doi:10.1007/978-3-031-25938-8_7
Treatment in the emergency department
Ling, Y., Chowdhury, D., & Wang, S. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823357-3.00005-7
Li, G., Duan, S., Zhu, T., Ren, Z., Xia, H., Wang, Z., Liu, L., & Liu, Z. (2023) · Figshare · doi:10.6084/m9.figshare.24159442
Evaluación de un sistema de identificación de fluctuaciones (estado ON/OFF) en enfermos de Parkinson
Barrachina, M. (2024) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.81685
Fernández‐Ferro, J., Ordás, C., Rejas, J., Ferro-Rey, B., Gómez-Lus, S., & Andrés, J. M. L. (2024) · Neurología · doi:10.1016/j.nrl.2023.05.006
Göbel, H. (2025) · Springer eBooks · doi:10.1007/978-3-662-68873-1_6
Anatomical study of the supraorbital and supratrochlear nerve from the endoscopic perspective
Wen, G.-D., Wu, X., Hu, K., Zeng, P., Liu, L., Chen, J., Yang, S., Huang, H.-H., Zhang, Y., & Wang, D. (2025) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2025.01.146
Raggi, A., D’Amico, D., Guastafierro, E., Ciusani, E., Montisano, D. A., Erbetta, A., Demichelis, G., Fedeli, D., Nigri, A., & Grazzi, L. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08327-z
A Randomized Trial of Cervical Stabilization Exercise Training Via Telerehabilitation for Migraine
Düşgün, E. S., Karahan, N., & Celenay, S. T. (2025) · Pain Management Nursing · doi:10.1016/j.pmn.2025.08.001
Obermeier, V., Murawski, M., Heinen, F., Landgraf, M. N., Straube, A., von Kries, R., & Ruscheweyh, R. (2021) · Figshare · doi:10.6084/m9.figshare.17056645
Sumelahti, M.-L., Sumanen, M. P. T., Sumanen, M. S., Tuominen, S., Vikkula, J., Honkala, S. M., Rosqvist, S., & Korolainen, M. A. (2020) · Figshare · doi:10.6084/m9.figshare.13023929
Metadata
- Authors
- Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., Varon, S. F., Blumenfeld, A. M., Katsarava, Z., Pascual, J., Lanteri-Minet, M., Cortelli, P., & Martelletti, P.
- Affiliations
- Allergan (United States) (US)
- Albert Einstein College of Medicine (US)
- University of California, San Francisco (US)
- Essen University Hospital (DE)
- Hospital Universitario Central de Asturias (ES)
- University of Bologna (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Corresponding author
- Bloudek, L. M.
- ORCID
- Venue
- The Journal of Headache and Pain
- Published
- 2012-05-29
- Volume
- 13
- Issue
- 5
- Pages
- 361-378
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC3381065
- OpenAlex
- W2094473459
- Cited by
- 339
- References
- 38
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 26 · 2023: 19 · 2022: 18 · 2021: 38 · 2020: 36 · 2019: 34 · 2018: 25 · 2017: 25 · 2016: 17 · 2015: 17 · 2014: 30 · 2013: 25 · 2012: 6
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- University of Washington
- Allergan
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- migraine, chronic migraine, episodic migraine, health care costs, direct medical costs, health care utilization, disability, psychiatric comorbidity, emergency department visits, hospital visits, diagnostic testing, medication use, cross-national comparison
- MeSH terms
- Cross-Sectional Studies, Europe, Female, Persons with Disabilities, Health Surveys, Humans, Male, Migraine Disorders, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
